White House Help Wanted List Worries Scientists

President George W. Bush's hesitance in filling top positions in science and engineering has the scientific community concerned about how funding policies may change and whether decisions will be based on research or rhetoric. Top positions remain unfilled at the National Institutes of Health, Food and Drug Administration, Environmental Protection Agency, Department of Energy (DOE), and Department of Agriculture. Bush even boasts the record for tardiness in choosing a White House science adviser

Written byMaria Anderson
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Bush has waited longer than any president, even former President Ronald Reagan (who named his adviser on May 19), to nominate a top-ranking science policy adviser, who could help him make key appointments in other departments. Bush supporters say the president has had quite a lot on his plate and that in the meantime, the staff of the OSTP manages White House science policy on its own. "There are about 35 people working in the office right now," says Richard Russell, OSTP chief of staff. "We are still up and running. We will see that the job gets done until the appointment is made."

Nonetheless, the high-placed vacancies have many in the science community questioning whether the president has any interest in consulting experts before making decisions in international trade diplomacy, or health funding. Scientists who want to plan their future grant schedules wonder how the government will manage its ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies